Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Company Analysis

AKTS Insider Trading

AKTS | Market Equity

Comprehensive Trading Performance Summary

The investment history of corporate insiders at AKTS provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Market Equity sector.

Transactions on Chart

Open Full Chart
Filing Date Trade Date Reporting Person Relationship Type Price Qty Total, $ Owned After Change, %
2021-08-25 00:01 2021-08-20 Aichele David Officer - EVP of Business Development SELL $8.23 1,480 $12,180 178,378 -0.8%
2021-07-21 00:02 2021-07-19 Houlden Rohan Officer - Chief Product Officer SELL $8.96 1,375 $12,320 133,647 -1.0%
2021-07-21 00:02 2021-07-16 Aichele David Officer - EVP of Business Development SELL $9.37 2,313 $21,673 179,858 -1.3%
2021-07-14 00:48 2021-07-12 Denbaars Steven Director SELL $9.93 7,000 $69,510 246,829 -2.8%
2021-04-15 00:06 2021-04-12 Denbaars Steven Director SELL $12.00 7,000 $84,000 253,829 -2.7%
2021-04-10 00:02 2021-04-07 Shealy Jeffrey B. Director, Officer - Chief Executive Officer SELL $12.27 200,000 $2,454,000 416,520 -32.4%
2021-03-25 00:02 2021-03-22 Aichele David Officer - EVP of Business Development SELL $13.72 5,000 $68,600 182,171 -2.7%
2021-03-18 00:21 2021-03-17 Boller Kenneth Officer - Interim CFO SELL $13.99 1,442 $20,174 73,158 -1.9%
2021-03-18 00:17 2021-03-15 Houlden Rohan Officer - Chief Product Officer SELL $13.82 1,375 $19,003 135,022 -1.0%
2021-03-18 00:15 2021-03-15 Shealy Jeffrey B. Director, Officer - Chief Executive Officer SELL $13.58 200,000 $2,715,000 936,239 -17.6%
2021-03-13 00:48 2021-03-11 Houlden Rohan Officer - Chief Product Officer SELL $14.13 99,800 $1,410,174 136,397 -42.3%
2021-02-11 01:02 2021-02-08 Shealy Jeffrey B. Director, Officer - Chief Executive Officer SELL $18.00 15,000 $270,000 1,136,239 -1.3%
2021-01-13 01:03 2021-01-11 Denbaars Steven Director SELL $13.40 7,000 $93,800 260,829 -2.6%
2021-01-13 01:03 2021-01-08 Geiss Arthur Director SELL $14.00 2,498 $34,972 112,640 -2.2%
2020-12-31 01:00 2020-12-28 RUDY SUZANNE B Director SELL $12.73 927 $11,801 95,237 -1.0%
2020-12-24 01:01 2020-12-21 Boller Kenneth Officer - Interim CFO SELL $11.05 1,900 $20,995 74,600 -2.5%
2020-12-24 01:00 2020-12-21 Houlden Rohan Officer - Chief Product Officer SELL $11.07 880 $9,742 236,197 -0.4%
2020-12-19 01:03 2020-12-16 Shealy Jeffrey B. Director, Officer - Chief Executive Officer SELL $10.54 34,000 $358,309 1,151,239 -2.9%
2020-12-15 01:02 2020-12-11 Aichele David Officer - EVP of Business Development SELL $8.62 3,000 $25,860 187,171 -1.6%
2020-12-12 01:04 2020-12-09 Shealy Jeffrey B. Director, Officer - Chief Executive Officer SELL $8.51 100,000 $851,000 1,185,239 -7.8%
2020-11-26 01:05 2020-11-24 Boller Kenneth Officer - Interim CFO SELL $7.66 500 $3,830 76,500 -0.6%
2020-11-26 01:04 2020-11-24 Houlden Rohan Officer - Chief Product Officer SELL $7.70 1,100 $8,470 237,077 -0.5%
2020-11-26 01:03 2020-11-23 Aichele David Officer - EVP of Business Development SELL $8.00 1,850 $14,800 190,171 -1.0%
2020-11-26 01:02 2020-11-23 Shealy Jeffrey B. Director, Officer - Chief Executive Officer SELL $7.74 100,000 $774,000 1,285,239 -7.2%
2020-11-18 01:03 2020-11-13 RUDY SUZANNE B Director SELL $7.83 11,132 $87,164 96,164 -10.4%
2020-11-13 01:00 2020-11-09 Geiss Arthur Director SELL $7.88 9,806 $77,283 115,138 -7.8%
2020-10-24 00:05 2020-10-22 McMahon Jeffrey Director SELL $8.00 29,990 $239,920 484,338 -5.8%
2020-10-24 00:04 2020-10-21 Shealy Jeffrey B. Director, Officer - Chief Executive Officer SELL $7.80 100,000 $780,000 1,385,239 -6.7%
2020-10-22 00:04 2020-10-19 McMahon Jeffrey Director SELL $8.00 10 $80 514,328 0.0%
2020-10-15 00:47 2020-10-12 Denbaars Steven Director SELL $8.53 7,000 $59,710 248,964 -2.7%
2020-10-03 00:01 2020-09-30 Shealy Jeffrey B. Director, Officer - Chief Executive Officer SELL $8.23 100,000 $823,000 1,485,239 -6.3%
2020-10-01 00:15 2020-09-28 Houlden Rohan Officer - Chief Product Officer SELL $8.37 2,200 $18,414 238,177 -0.9%
2020-09-26 00:10 2020-09-25 Aichele David Officer - EVP of Business Development SELL $8.04 1,400 $11,256 192,021 -0.7%
2020-09-26 00:09 2020-09-23 Shealy Jeffrey B. Director, Officer - Chief Executive Officer SELL $8.16 32,500 $265,151 2,929,562 -1.1%
2020-09-17 00:03 2020-09-14 Houlden Rohan Officer - Chief Product Officer SELL $7.64 8,750 $66,850 240,377 -3.5%
2020-08-26 00:04 2020-08-21 Boller Kenneth Officer - Interim CFO SELL $8.58 1,400 $12,012 62,000 -2.2%
2020-08-26 00:03 2020-08-21 Houlden Rohan Officer - Chief Product Officer SELL $8.58 1,400 $12,012 224,127 -0.6%
2020-08-26 00:03 2020-08-21 Aichele David Officer - EVP of Business Development SELL $8.65 1,500 $12,975 168,421 -0.9%
2020-08-14 00:42 2020-08-11 Aichele David Officer - EVP of Business Development SELL $7.82 1,900 $14,858 169,921 -1.1%
2020-07-25 00:05 2020-07-22 McMahon Jeffrey Director SELL $8.04 20,000 $160,800 514,338 -3.7%
2020-07-22 00:21 2020-07-17 Houlden Rohan Officer - Chief Product Officer SELL $7.90 2,200 $17,380 225,527 -1.0%
2020-07-18 00:01 2020-07-16 Aichele David Officer - EVP of Business Development SELL $7.79 2,350 $18,307 171,821 -1.3%
2020-06-27 00:09 2020-06-24 Shealy Jeffrey B. Director, Officer - Chief Executive Officer SELL $8.41 34,000 $285,831 2,912,062 -1.2%
2020-06-18 23:49 2020-06-16 Shealy Jeffrey B. Director, Officer - Chief Executive Officer SELL $7.85 100,000 $784,500 2,946,062 -3.3%
2020-06-03 23:50 2020-06-01 Denbaars Steven Director SELL $7.68 7,000 $53,760 255,831 -2.7%
2020-04-16 00:15 2020-04-15 Aichele David Officer - EVP of Business Development SELL $7.59 4,000 $30,360 174,171 -2.2%
2020-04-16 00:09 2020-04-13 Denbaars Steven Director SELL $7.59 7,000 $53,130 262,831 -2.6%
2020-04-16 00:06 2020-04-13 McMahon Jeffrey Director SELL $8.01 20,000 $160,172 534,338 -3.6%
2020-04-04 00:26 2020-04-01 Shealy Jeffrey B. Director, Officer, 10% owner - Chief Executive Officer SELL $4.69 100,000 $468,500 3,046,062 -3.2%
2020-03-27 23:57 2020-03-25 Shealy Jeffrey B. Director, Officer, 10% owner - Chief Executive Officer SELL $4.66 32,500 $151,551 3,146,062 -1.0%
SHOW ENTRIES

How to Interpret $AKTS Trades

Not every insider transaction in AKTS is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $AKTS shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.

Data Source & Accuracy for AKTS

Insider activity data for AKTS is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $AKTS, allowing you to follow the capital of those with the most intimate knowledge of the company.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.